Effect of Linezolid on Clinical Severity and Pulmonary Cytokines in a Murine Model of Influenza A and Staphylococcus aureus Coinfection

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Liu, Xinyan ^a   He, Yaling ^a,c   Xiao, Kun ^a   White, Julie R ^a   Fusco, Dahlene N ^a,b,d   Papanicolaou, Genovefa A ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE CHEMOATTRACTANT; LINEZOLID; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; INFLUENZA A; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIXED INFECTION; MOUSE; NONHUMAN; VIRAL CLEARANCE; WEIGHT CHANGE;

ACETAMIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; COINFECTION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERLEUKINS; LUNG; MICE; MICE, INBRED C57BL; OXAZOLIDINONES; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VIRAL LOAD; WEIGHT LOSS;

EID: 84874589858     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057483     Document Type: Article

References (46)

1. Murray RJ, Robinson JO, White JN, Hughes F, Coombs GW, et al. (2010) Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection. PLoS One 5: e8705.
2. Centers for Disease Control and Prevention (CDC) (2009) Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. MMWR Morb Mortal Wkly Rep 58: 1071-1074.
3. Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, et al. (2008) Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 122: 805-811.
4. Centers for Disease Control and Prevention (CDC) (2007) Severe methicillin resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 56: 325-329.
5. Lee MH, Arrecubieta C, Martin FJ, Prince A, Borczuk AC, et al. (2010) A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis 201: 508-515.
6. Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME, et al. (2011) Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 203: 880-888.
7. Yao L, Berman JW, Factor SM, Lowy FD, (1997) Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection. Infect Immun 65: 3889-3895.
8. Ventura CL, Higdon R, Hohmann L, Martin D, Kolker E, et al. (2008) Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia. Infect Immun 76: 5862-5872.
9. Bubeck Wardenburg J, Schneewind O, (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205: 287-294.
10. Goodman RB, Pugin J, Lee JS, Matthay MA, (2003) Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 14: 523-535.
11. Banerjee A, Stevenaert F, Pande K, Haghjoo E, Antonenko S, et al. (2010) Modulation of paired immunoglobulin-like type 2 receptor signaling alters the host response to Staphylococcus aureus-induced pneumonia. Infect Immun 78: 1353-1363.
12. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A, (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822.
13. Aoki N, Xing Z, (2004) Use of cytokines in infection. Expert Opin Emerg Drugs 9: 223-236.
14. Zhao YX, Nilsson IM, Tarkowski A, (1998) The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology 93: 80-85.
15. Yamada M, Gomez JC, Chugh PE, Lowell CA, Dinauer MC, et al. (2011) Interferon-gamma production by neutrophils during bacterial pneumonia in mice. Am J Respir Crit Care Med 183: 1391-1401.
16. Parker D, Prince A, (2011) Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol 45: 189-201.
17. van der Sluijs KF, van der Poll T, Lutter R, Juffermans NP, Schultz MJ, (2010) Bench-to-bedside review: bacterial pneumonia with influenza- pathogenesis and clinical implications. Crit Care 14: 219.
18. Hennet T, Ziltener HJ, Frei K, Peterhans E, (1992) A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 149: 932-939.
19. Fritz RS, Hayden FG, Calfee DP, Cass LM, Peng AW, et al. (1999) Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis 180: 586-593.
20. Sun J, Madan R, Karp CL, Braciale TJ, (2009) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15: 277-284.
21. van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Pater JM, et al. (2004) IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 172: 7603-7609.
22. Mufson MA, Stanek RJ, (2006) Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia. Clin Infect Dis 42: 304-306.
23. Martinez FJ, (2004) Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. Clin Infect Dis 38Suppl 4: S328-340.
24. Baddour LM, Yu VL, Klugman KP, Feldman C, Ortqvist A, et al. (2004) Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170: 440-444.
25. Karlstrom A, Boyd KL, English BK, McCullers JA, (2009) Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. J Infect Dis 199: 311-319.
26. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, et al. (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52: 285-292.
27. Barman TK, Pandya M, Mathur T, Bhadauriya T, Rao M, et al. (2009) Novel biaryl oxazolidinones: in vitro and in vivo activities with pharmacokinetics in an animal model. Int J Antimicrob Agents 33: 280-284.
28. Leach KL, Brickner SJ, Noe MC, Miller PF, (2011) Linezolid, the first oxazolidinone antibacterial agent. Ann N Y Acad Sci 1222: 49-54.
29. Welshman IR, Sisson TA, Jungbluth GL, Stalker DJ, Hopkins NK, (2001) Linezolid absolute bioavailability and the effect of food on oral bioavailability. Biopharm Drug Dispos 22: 91-97.
30. Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, et al. (2012) Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 54: 621-629.
31. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH, (2003) Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124: 1789-1797.
32. Garcia-Roca P, Mancilla-Ramirez J, Santos-Segura A, Fernandez-Aviles M, Calderon-Jaimes E, (2006) Linezolid diminishes inflammatory cytokine production from human peripheral blood mononuclear cells. Arch Med Res 37: 31-35.
33. Danin J, Linder L, Lundqvist G, Wretlind B, (2003) Cytokines in periradicular lesions: the effect of linezolid treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 492-498.
34. Fusco D, Liu X, Savage C, Taur Y, Xiao W, et al. (2010) Echinacea purpurea aerial extract alters course of influenza infection in mice. Vaccine 28: 3956-3962.
35. Tobita K, Sugiura A, Enomote C, Furuyama M, (1975) Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol 162: 9-14.
36. Nguyen JT, Smee DF, Barnard DL, Julander JG, Gross M, et al. (2012) Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. PLoS One 7: e31006.
37. Tessier PR, Keel RA, Hagihara M, Crandon JL, Nicolau DP, (2012) Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model. Antimicrob Agents Chemother 56: 2342-2346.
38. Bouvier NM, Lowen AC, (2010) Animal Models for Influenza Virus Pathogenesis and Transmission. Viruses 2: 1530-1563.
39. Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB, (2004) Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol 172: 3377-3381.
40. von Kockritz-Blickwede M, Rohde M, Oehmcke S, Miller LS, Cheung AL, et al. (2008) Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am J Pathol 173: 1657-1668.
41. Sun K, Metzger DW, (2008) Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 14: 558-564.
42. Lijek RS, Weiser JN, (2012) Co-infection subverts mucosal immunity in the upper respiratory tract. Curr Opin Immunol 24: 417-423.
43. Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, et al. (1990) Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141: 94-97.
44. Nathan C, (2006) Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6: 173-182.
45. Schroder K, Hertzog PJ, Ravasi T, Hume DA, (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189.
46. Verhoeven D, Teijaro JR, Farber DL, (2009) Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection. Virology 390: 151-156.